UBE2U,or "Ubiquitin-Conjugating Enzyme E2 U," is a protein that in humans is encoded by the UBE2U gene. This enzyme is a member of the ubiquitin-conjugating (E2) enzyme family, playing a crucial role in the ubiquitination pathway, a fundamental process for protein degradation and regulation within the cell.Ubiquitination is a process where ubiquitin, a small regulatory protein, is attached to substrates, typically signaling them for degradation via the proteasome or altering their cellular location, activity, or interactions. UBE2U functions as an E2 enzyme, which is responsible for the transfer of ubiquitin from the E1 activating enzyme to specific substrates, often with the assistance of an E3 ubiquitin ligase.The specific substrates and biological functions of UBE2U are still under research, but given the general importance of ubiquitination in cellular regulation, it is likely involved in multiple critical cellular processes. This can include cell cycle regulation, DNA repair, and response to stress or external stimuli.
UBE2U's role in ubiquitination suggests its involvement in various disease pathways, particularly those where protein degradation and regulation are disrupted, such as in cancer, neurodegenerative disorders, and inflammatory conditions. Abnormalities in ubiquitination processes are linked to the pathogenesis of these diseases, highlighting the significance of enzymes like UBE2U in maintaining cellular homeostasis.In summary, UBE2U is an important component of the ubiquitination pathway, with roles in various cellular processes and disease mechanisms. As such, it remains a subject of active research in the field of molecular biology and biochemistry.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
El MG132, un inhibidor del proteasoma, puede afectar a las vías ubiquitina-proteasoma, lo que podría influir en la función de UBE2U. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Otro inhibidor del proteasoma, Bortezomib, podría influir indirectamente en UBE2U al afectar a las vías de degradación de proteínas. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
La lactocistina, un inhibidor específico del proteasoma, puede modular los procesos de ubiquitinación, afectando potencialmente a UBE2U. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41, un inhibidor de la enzima activadora de la ubiquitina E1, podría afectar indirectamente a la actividad de UBE2U en la vía de la ubiquitinación. | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
Inhibe l'USP14, une enzyme de déubiquitination, influençant potentiellement les voies d'ubiquitination impliquant l'UBE2U. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modula las vías de degradación de proteínas, podría tener efectos indirectos sobre la actividad de UBE2U. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Un fármaco inmunomodulador, puede influir en la homeostasis de las proteínas y potencialmente en la función UBE2U. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Similar a la Talidomida, afecta a las vías de degradación de proteínas, impactando potencialmente en UBE2U. | ||||||